Connect with us

Hi, what are you looking for?

Trade Strategy LabTrade Strategy Lab

Business

Lyft co-founders to step down from ride-hailing firm’s board

Lyft said Thursday its co-founders, Logan Green and John Zimmer, are stepping down from the ride-hailing services provider’s board, following the completion of a two-year transition plan.

Green and Zimmer began serving as the chair and vice chair of Lyft’s board in 2023 after stepping down as CEO and president, respectively, handing the reins to David Risher, who has been a board member since 2021.

The duo founded Lyft in 2012, with the company now operating across four continents and nearly 1,000 cities.

Sean Aggarwal, who was the chair of Lyft’s board from 2019 to 2023, will reprise his role.

Zimmer is launching a new consumer-focused business venture named YES&, while Green will continue as a venture partner at Autotech Ventures, a firm investing in the mobility and transportation sector.

Lyft, which recently completed its nearly $200 million acquisition of European mobility platform FreeNow, has signed a deal with China’s Baidu 9888.HK to introduce the search-engine giant’s robotaxis in the region.

It posted revenue of $1.59 billion in the second quarter, missing estimates of $1.61 billion, according to data compiled by LSEG.

Rides on Lyft’s platform grew 14% to a record high of 234.8 million in the quarter, slightly below estimates of 235.9 million, per Visible Alpha.

This post appeared first on NBC NEWS

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Investing

Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...

Business

A nationwide coordinated crackdown on retail crime — what authorities are calling the first of its kind — led to hundreds of arrests in...

Investing

Phase 1 1 First-In-Human study designed to assess safety   ,   tolerability   , right dose for Phase 2 and early signs of...

Stock

Over the past five sessions, the Indian equity markets headed nowhere and continued consolidating in a defined range. In the previous weekly note, it...